TNF Pharmaceuticals Statistics
Total Valuation
TNFA has a market cap or net worth of $1.98 million. The enterprise value is -$3.90 million.
Important Dates
The next estimated earnings date is Monday, August 18, 2025, before market open.
| Earnings Date | Aug 18, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TNFA has 14.18 million shares outstanding. The number of shares has increased by 87.27% in one year.
| Current Share Class | 14.18M |
| Shares Outstanding | 14.18M |
| Shares Change (YoY) | +87.27% |
| Shares Change (QoQ) | +86.07% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 1.39% |
| Float | 14.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.12 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.37, with a Debt / Equity ratio of 0.00.
| Current Ratio | 1.37 |
| Quick Ratio | 1.19 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -121.95% and return on invested capital (ROIC) is -43.26%.
| Return on Equity (ROE) | -121.95% |
| Return on Assets (ROA) | -31.36% |
| Return on Invested Capital (ROIC) | -43.26% |
| Return on Capital Employed (ROCE) | -60.30% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$9.05M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.39% in the last 52 weeks. The beta is 2.42, so TNFA's price volatility has been higher than the market average.
| Beta (5Y) | 2.42 |
| 52-Week Price Change | -93.39% |
| 50-Day Moving Average | 0.19 |
| 200-Day Moving Average | 0.86 |
| Relative Strength Index (RSI) | 36.69 |
| Average Volume (20 Days) | 7,351,150 |
Short Selling Information
The latest short interest is 2.13 million, so 14.99% of the outstanding shares have been sold short.
| Short Interest | 2.13M |
| Short Previous Month | 2.78M |
| Short % of Shares Out | 14.99% |
| Short % of Float | 15.01% |
| Short Ratio (days to cover) | 0.75 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.35M |
| Pretax Income | -12.29M |
| Net Income | -18.10M |
| EBITDA | n/a |
| EBIT | -8.35M |
| Earnings Per Share (EPS) | -$5.59 |
Full Income StatementBalance Sheet
The company has $5.88 million in cash and $2,678 in debt, giving a net cash position of $5.88 million or $0.41 per share.
| Cash & Cash Equivalents | 5.88M |
| Total Debt | 2,678 |
| Net Cash | 5.88M |
| Net Cash Per Share | $0.41 |
| Equity (Book Value) | 13.84M |
| Book Value Per Share | 1.16 |
| Working Capital | 1.84M |
Full Balance SheetCash Flow
| Operating Cash Flow | -9.86M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |